Frank S. O.

Accredited Investor @Nufund Venture Group

Austin, TX, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2025 — Present

Accredited Investor @Nufund Venture Group

View department →

Founded in San Diego, CA, NuFund is one of the largest, most active and most successful early-stage investor groups over the past 20+ years. We represent diverse backgrounds and perspectives, and work together to foster a culture of excellence, respect, innovation, and fun.

EDUCATION

N/A

David Geffen School of Medicine at UCLA

Residency, Family Medicine

N/A

Stanford University

Biodesign

N/A

David Geffen School of Medicine at UCLA

Fellowship, Clinical Molecular Genetics

N/A

University of Southern California

Gerontology

N/A

Keck School of Medicine of the University of Southern California

Doctor of Medicine (M.D.), Medicine

ABOUT FRANK S. O.

As the CEO of Compass Bioinformatics, I lead a team of experienced AI engineers, software developers, bioinformaticians, commercial sales leaders and clinical genetics professionals in providing generative-Al and machine learning (ML)-based bioinformatics platforms and services to analyze complex next-generation sequencing data for rare and inherited disorders. With offices in Hsinchu, Taiwan; Tokyo, Japan; and Austin, Texas, we serve patients and customers in the biotech, research, and medical/clinical arenas.I have a strong background in medicine, having completed my residency in Family Medicine and fellowship in Clinical Molecular Genetics at the David Geffen School of Medicine at UCLA. I also hold a Doctor of Medicine degree from the Keck School of Medicine of the University of Southern California and a Biodesign degree from Stanford University. My passion is to leverage my expertise in AI, ML, and bioinformatics to transform patient care through advanced genomic and molecular technologies. I have served as the Group Chief Medical Officer at Prenetics, a leading genomics and precision oncology company that recently acquired ACT Genomics, the only Asia-based company to receive FDA clearance, where I served as interim CEO. Over the last 20 years, I’ve held leadership roles at leading companies such as Roche, Illumina, QIAGEN, Guardant and Everly Health.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.